Skip to main content
In a Roundup case, a Philadelphia jury awarded $175 million in damages

In a Roundup case, a Philadelphia jury awarded $175 million in damages

The original maker of the herbicide Monsanto, was sued by a man who claimed to have used more than 500 gallons of Roundup for lawns and gardens between 1989 and 2014 before developing non-Hodgkin's lymphoma.

The three-week jury trial in Philadelphia Common Pleas Court was intended to examine whether glyphosate, the active ingredient in Roundup, is carcinogenic when in the presence of other compounds.

A prominent ingredient in Roundup and other products, including Ranger Pro, glyphosate has been around since the 1970s, and activists often criticize it for its use in modern agriculture. The lawyers of Bayer have long argued that numerous studies have proven Roundup safe, and the EPA has concluded that it is not carcinogenic.

The safety of glyphosate has been affirmed by nearly all scientific bodies and research associated with it.

Over 30,000 glyphosate-related claims remain unresolved, with Bayer allocating about $16 billion for their settlements.

Often hailed as one of the safest herbicides available, Roundup is the most common weed killer in the U.S. Many in the agricultural sector are frustrated that most of the litigation against Monsanto and Bayer relies largely on emotional testimony rather than scientific evidence.